
CEO Rob Fried details Niagen Bioscience’s NAD+ business and April 28 telehealth launch in an exclusive interview with LA Times Studios. Niagen Bioscience spent decades following the science on NAD+ be...
CEO Rob Fried details Niagen Bioscience’s NAD+ business and April 28 telehealth launch in an exclusive interview with LA Times Studios. Niagen Bioscience spent decades following the science on NAD+ be...